Preferred Label : Trifluridine and Tipiracil Hydrochloride;
NCIt synonyms : Tipiracil Hydrochloride Mixture with Trifluridine; Thymidine, Alpha,alpha,alpha-trifluoro-, Mixt. with 5-Chloro-6-((2-imino-1-pyrrolidinyl)methyl)-2,4(1H,3H)-pyrimidinedione
Monohydrochloride; Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102; Trifluridine/Tipiracil; FTD-TPI;
NCIt related terms : Trifluridine and tipiracil;
NCIt definition : An orally bioavailable combination agent composed of the cytotoxic pyrimidine analog
trifluridine (5-trifluoro-2'-deoxythymidine or TFT) and a thymidine phosphorylase
inhibitor (TPI) tipiracil hydrochloride, in a molar ratio of 1.0:0.5 (TFT:TPI), with
potential antineoplastic activity. After oral administration of TAS-102, TFT is phosphorylated
to the active monophosphate form TF-TMP, which binds covalently to the active site
of thymidylate synthase, thereby reducing the nucleotide pool levels required for
DNA replication. Furthermore, the triphosphate form TF-TTP can be incorporated into
DNA, which induces DNA fragmentation and leads to the inhibition of tumor growth.
TPI exhibits a dual effect: 1) an anti-angiogenic effect mediated through the inhibition
of thymidine phosphorylase, which plays important role in nucleotide metabolism and
a variety of development processes, including angiogenesis, 2) increased bioavailability
of the normally short-lived antimetabolite TFT by preventing its degradation into
the inactive form trifluorothymine (TF-Thy). The synergistic effect of the components
in TAS-10 may demonstrate antitumor activity in 5-FU-resistant cancer cells.;
CAS number : 733030-01-8;
Drug name : Lonsurf;
Molecule name : TAS-102; TAS 102;
Codes from synonyms : 516;
Origin ID : C102554;
UMLS CUI : C4682386;
Automatic exact mappings (from CISMeF team)
Semantic type(s)
concept_is_in_subset
has_target
is_component_of_chemotherapy_regimen
http://www.has-sante.fr/portail/jcms/c_2723464/fr/lonsurf
https://www.has-sante.fr/portail/jcms/c_2723464/fr/lonsurf-trifluridine-/-tipiracil-analogue-de-la-pyrimidine
2016
false
false
false
France
French
drug combinations
treatment outcome
antimetabolites, antineoplastic
antimetabolites, antineoplastic
adult
trifluridine, combinations
colorectal neoplasms
neoplasm metastasis
Metastatic colorectal cancer
administration, oral
aged
evaluation of the transparency committee
insurance, health, reimbursement
survival analysis
Trifluridine and Tipiracil Hydrochloride
guidelines for drug use
trifluridine tipiracil drug combination
tipiracil
trifluridine
pyrrolidines
thymine
---
https://www.ema.europa.eu/medicines/human/EPAR/Lonsurf
2016
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
trifluridine
drug combinations
drug approval
europe
treatment outcome
antimetabolites, antineoplastic
antimetabolites, antineoplastic
adult
product surveillance, postmarketing
trifluridine, combinations
colorectal neoplasms
neoplasm metastasis
Metastatic colorectal cancer
administration, oral
aged
drug interactions
pregnancy
breast feeding
contraception
drug evaluation, preclinical
Trifluridine and Tipiracil Hydrochloride
trifluridine tipiracil drug combination
trifluridine tipiracil drug combination
tipiracil
tipiracil
trifluridine
pyrrolidines
thymine
pyrrolidines
thymine
---